Pay in 4 interest-free payments of $75.00 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
/ DAG1(371-383)-Man(379) / Dystroglycan1
33 / Anti-Epileptic / rac-Brivaracetam-d7 / (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide-d7
5-Amino-2-hydroxybenzoic Acid-d3
5-Aminosalicylic Acid-d3
MV100130: Tris-GalNAc-β-Ala-PEG3-FITC label-new / DAG1(371-383)-Man(379) / Dystroglycan1C94H143N13O37S 2079. 3 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, extended through a alanine linker and a discrete, monodisperse triethylene glycol (PEG3) spacer to a fluorescein isothiocyanate (FITC) reporter. The FITC label enables fluorescence detection and imaging of ASGPR mediated uptake, hepatocyte targeting, and binding studies. This compound enables the
US$ 156.00
US$ 50.00
US$ 50.00
US$ 50.00
US$ 35.00
US$ 50.00
US$ 19.99
US$ 50.00
